BuyCancerDrugs.com BuyCancerDrugs.com
BuyCancerDrugs.com BuyCancerDrugs.com
OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer
Search OncologyJournal.org
Browse by Cancer Type or Cancer Drug

Go Back   OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer > Blogs > admin
Connect with Facebook


Decitabine
Old

Eisai Announces Results Of Phase III Study Of Dacogen For Injection in AML

Posted 07-05-2010 at 05:26 PM by admin
Eisai Announces Results Of Phase III Study Of Dacogen(R) (Decitabine) For Injection In Acute Myeloid Leukemia (AML)

Article Date: 04 Jul 2010 - 0:00 PDT

Eisai Inc. announced preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults. ...
Administrator
Comments 0 admin is offline
Old

Late-stage ovarian cancer shows promise in 2-drug phase I trial

Posted 06-10-2010 at 05:07 PM by admin
Public release date: 9-Jun-2010

INDIANAPOLIS -- The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.

Advanced...
Administrator
Comments 0 admin is offline
Old

Vidaza to Keep Propri. Clin. Gold Stand. Status for Myelodysplastic Syndromes Treat.

Posted 04-28-2010 at 04:24 PM by admin
Celgene's Vidaza to Retain Proprietary Clinical Gold Standard Status for the Treatment of Myelodysplastic Syndromes

TradingMarkets.com
Posted on: Wed, 28 Apr 2010 00:59:22 EDT

Apr 28, 2010 (Close-Up Media via COMTEX)

Decision Resources, a research and advisory firms for pharmaceutical and healthcare issues, finds that Celgene's Vidaza (azacitidine) (seven-day dosing) will retain Decision Resources' proprietary clinical gold standard status through 2013...
Administrator
Comments 0 admin is offline
Old

Decitabine Shows Promise in Elderly Patients With Acute Myeloid Leukaemia

Posted 04-08-2010 at 03:21 PM by admin
Doctor's Guide
DGNews

WASHINGTON, DC -- April 5, 2010 -- A genetic treatment for leukaemia may improve remission and survival outcomes in elderly patients compared to existing remedies such as intensive chemotherapy, according to a report published in the latest issue of Proceedings of the National Academy of Sciences (PNAS).

Carlo Croce, MD, Department of Immunology and Medical Genetics, Ohio State University, Columbus, Ohio, and colleagues administered decitabine,...
Administrator
Comments 0 admin is offline
Old

Updated NCCN Guide. for AML Include Risk Stratification to Assist in Treat. Selection

Posted 10-22-2009 at 06:55 PM by admin
Source: Reuters.com

Mon Oct 19, 2009 8:31am EDT

Updated NCCN Guidelines for AML Include Risk Stratification to Assist in
Treatment Selection

The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Acute Myeloid Leukemia (AML), the most common acute leukemia affecting adults. Noteworthy updates include the incorporation of risk stratification based on white blood cell count, the alternative to use cord blood in allogeneic...
Administrator
Comments 0 admin is offline


All times are GMT. The time now is 02:19 PM.


Powered by vBulletin® Version 3.8.1
Copyright ©2000 - 2010, Jelsoft Enterprises Ltd.